Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Thorac Oncol. 2014 Nov;9(11):1669–1674. doi: 10.1097/JTO.0000000000000344

Table 2.

Secondary Lung Cancer with KRAS Mutations

Patient BRAF mutation Type of Second Lung Cancer Months Between
1 G469A Metachronous with KRAS G12D 43 months
2 G469A Metachronous with KRAS G13C 15 months
3 V600E Metachronous with KRAS G12V 50 months
4 G469V Synchronous with KRAS G12C --
5 V600E Synchronous with KRAS G12C --
6 G469A Synchronous with KRAS G12C --